McGroarty Jeffrey Brian 4
4 · Annovis Bio, Inc. · Filed Dec 8, 2021
Insider Transaction Report
Form 4
McGroarty Jeffrey B
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-06+165,199→ 165,199 totalExercise: $20.97Exp: 2031-12-06→ Common Stock (165,199 underlying) - Award
Stock Option (right to buy)
2021-12-06+30,396→ 30,396 totalExercise: $20.97From: 2021-12-06Exp: 2031-12-06→ Common Stock (30,396 underlying)
Footnotes (2)
- [F1]The stock option is 100% vested.
- [F2]The stock option shall vest in two installments: (i) the first installment of 82,600 shares on March 31, 2022 and (ii) a second and final installment of 82,599 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.